Correlation Between Replimune and Enliven Therapeutics
Can any of the company-specific risk be diversified away by investing in both Replimune and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Replimune and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Replimune Group and Enliven Therapeutics, you can compare the effects of market volatilities on Replimune and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Replimune with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Replimune and Enliven Therapeutics.
Diversification Opportunities for Replimune and Enliven Therapeutics
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Replimune and Enliven is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Replimune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Replimune Group are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Replimune i.e., Replimune and Enliven Therapeutics go up and down completely randomly.
Pair Corralation between Replimune and Enliven Therapeutics
Given the investment horizon of 90 days Replimune Group is expected to generate 1.14 times more return on investment than Enliven Therapeutics. However, Replimune is 1.14 times more volatile than Enliven Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Enliven Therapeutics is currently generating about -0.09 per unit of risk. If you would invest 1,234 in Replimune Group on October 24, 2024 and sell it today you would lose (49.00) from holding Replimune Group or give up 3.97% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Replimune Group vs. Enliven Therapeutics
Performance |
| Timeline |
| Replimune Group |
| Enliven Therapeutics |
Replimune and Enliven Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Replimune and Enliven Therapeutics
The main advantage of trading using opposite Replimune and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Replimune position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.| Replimune vs. Nuvalent | Replimune vs. Ventyx Biosciences | Replimune vs. Ascendis Pharma AS | Replimune vs. United Therapeutics |
| Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |